Israel’s Teva is partnering with the Technion for research into new immunotherapy methods to treat cancer and nervous system diseases.

Technion President Peretz Lavie says the establishment of the centers places the university 'at the forefront of scientific research in efforts to eradicate the disease.'

Founded in 2016, CytoReason already has partnerships with top global pharmaceutical companies.

To mark World Cancer Day, NoCamels is highlighting some recent findings in research, clinical trials, detection methods, and new therapies - all from so far this year.

Israeli biotech company Accelerated Evolution Biotechnologies says it developed a cure for all cancers; top scientists and researchers issue warnings.

As 2018 ends, NoCamels looks at the top stories that captivated our readers most over the past year.

Alpha Tau Medical's Alpha DaRT technology delivers high-precision alpha radiation that decays inside tumor, killing cancer cells while sparing surrounding healthy tissue.

Trialjectory, with offices in Tel Aviv and New York, launched a unique service that connects cancer sufferers with clinical trials that are relevant specifically to them.

From AI algorithms set to transform diagnoses to new urine and blood tests, these are the cancer-related developments so far this year

After having founded and served in key roles in 6 successful Medtech companies, two Israeli medical entrepreneurs team up to save lives using cutting-edge imaging

November 1, 2017 | Six research teams made up mainly of Israeli and Canadian scientists have been awarded $5 million in funding to advance cancer research in their respective fields. The six teams were selected out of 56 proposals in the framework of the Joint Canada-Israel Health Research Program launched two years ago. The winning […]

| November 24, 2016 | Scientists and researchers from around the world gathered this week in Israel for the inauguration of the Technion Integrated Cancer Center (TICC), a first-of-its kind hub for global cancer research, which will expedite the discovery of new diagnostic tools and treatments through a collaborative “bench-to-bedside”approach.  In addition to serving as […]

Studying the different evolutionary stages of cells can help scientists identify tumors at various stages of cancer, following a new method developed at the Technion.